American Academy of Dermatology Association Statement on Reports on Counterfeit Injectables

ROSEMONT, Ill. (Apr. 11, 2024) — The American Academy of Dermatology Association is alarmed by reports of patients suffering from illnesses resembling botulism after undergoing procedures that use possible counterfeit botulinum toxin, also known as botox. The concerning rise in counterfeit injectables poses a grave threat to patient safety, potentially resulting in severe complications such as visual impairment, blindness, infection or even stroke.